Cytodyn Inc (CYDY)

[The Lawman]

Ibalilzumab is IV only, requires a hospital visit, and is only being tested for salvage patients where nothing else works. In addition, unlike PRO 140, which has no toxicities, Ibalilzumab has many serious side effects.

As for the Phase II combo trial, my guess is that results will be announced sometime during the second half of July.

Phase III mono trial has 100 patients, and my guess is they will announce results by YE 2017.

Tony C recently put up $1M of his own money into the latest private placement, and directors Dockery and Naydenov have invested millions of their own dollars as well.

Insiders don't invest their own money unless they are confident in the company's success, and CYDY insiders know far more than anyone on this board as to the future prospects for the this company.